World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
18956
World Ranking
2569
National Ranking
1226

Ivelin S. Georgiev publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ivelin S. Georgiev sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 162 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ivelin S. Georgiev D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ivelin S. Georgiev sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ivelin S. Georgiev is affiliated with Vanderbilt University Medical Center in the United States. Their research spans multiple areas within medicine and related biological sciences, with a particular focus on infectious diseases and immunology.

Their main fields of study are:

  • Medicine
  • Immunology and Microbiology

Within these areas, subfields of study include:

  • Infectious Diseases
  • Virology
  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Molecular Biology

The topics of their work cover various subjects, notably:

  • HIV Research and Treatment
  • Monoclonal and Polyclonal Antibodies Research
  • SARS-CoV-2 and COVID-19 Research
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies

Frequent coauthors in their publications include:

  • Nagarajan Raju
  • James E. Crowe
  • Andrea R. Shiakolas
  • Robert H. Carnahan
  • Naveenchandra Suryadevara

Their research has been published in several venues with multiple contributions, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • PLoS Pathogens
  • Cell Reports
  • Nature Medicine

Notable recent papers authored or coauthored by Ivelin S. Georgiev are:

  • Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor (2020), Nature Medicine
  • Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions (2021), Cell Reports Medicine
  • Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine (2022), Nature Communications
  • Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking (2022), Nature Biotechnology
  • Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease (2020), Science Immunology

Best Publications

  • Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.

    Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Structure and immune recognition of trimeric pre-fusion HIV-1 Env

    Marie Pancera;Tongqing Zhou;Aliaksandr Druz;Ivelin S. Georgiev

  • Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

    Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore

  • Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

    Florian Klein;Ron Diskin;Ron Diskin;Johannes F. Scheid;Johannes F. Scheid;Christian Gaebler;Christian Gaebler

  • Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface

    Jinghe Huang;Byong H. Kang;Marie Pancera;Jeong Hyun Lee

  • Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2

    Morgane Rolland;Paul T. Edlefsen;Brendan B. Larsen;Sodsai Tovanabutra

  • Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B and G

    Guillaume B.E. Stewart-Jones;Cinque Soto;Thomas Lemmin;Thomas Lemmin;Gwo Yu Chuang

  • Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

    Joan O. Ngwuta;Man Chen;Kayvon Modjarrad;Kayvon Modjarrad;M. Gordon Joyce

  • Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies.

    Tongqing Zhou;Jiang Zhu;Xueling Wu;Stephanie Moquin

  • Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

    Jinghe Huang;Byong H. Kang;Elise Ishida;Tongqing Zhou

  • Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env

    Young Do Kwon;Marie Pancera;Priyamvada Acharya;Ivelin S. Georgiev

  • Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

    Rui Kong;Kai Xu;Tongqing Zhou;Priyamvada Acharya

  • Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

    M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  • Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors

    Tongqing Zhou;Rebecca M. Lynch;Lei Chen;Priyamvada Acharya

  • Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

    Mattia Bonsignori;Tongqing Zhou;Zizhang Sheng;Lei Chen

  • Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

    Rebecca S. Rudicell;Young Do Kwon;Sung-Youl Ko;Amarendra Pegu

  • High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

    Ian Setliff;Andrea R. Shiakolas;Kelsey A. Pilewski;Amyn A. Murji

  • Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

    Masaru Kanekiyo;M Gordon Joyce;M Gordon Joyce;Rebecca A Gillespie;John R Gallagher

  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

    K. Xu;P. Acharya;R. Kong;C. Cheng

Frequent Co-Authors

Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
John R. Mascola
John R. Mascola ModeX Therapeutics
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Yongping Yang
Yongping Yang National Institutes of Health
Marie Pancera
Marie Pancera Fred Hutchinson Cancer Research Center
Sijy O'Dell
Sijy O'Dell National Institute of Allergy and Infectious Diseases
M. Gordon Joyce
M. Gordon Joyce Henry M. Jackson Foundation
Mark K. Louder
Mark K. Louder National Institute of Allergy and Infectious Diseases
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. Nursing programs, for example, often complement immunology knowledge with clinical practice. If you’re considering nursing as a pathway, exploring which lpn programs are easiest to get into can help you start quickly with a foundational healthcare role.

Advanced practice roles like Nurse Practitioners combine patient care with specialized knowledge. Those looking for a smoother academic journey might find the easiest nurse practitioner program a helpful starting point, ensuring a balance between quality and manageable course demands.

For nurses focusing on mental health and psychiatric care, online options are increasingly available. Programs like pmhnp programs online with best clinical placement provide strong hands-on experiences, crucial for building practical skills that support immunological research and patient treatment in psychiatric settings.

Cost can also be a significant factor. Prospective students should consider the cheapest pmhnp certificate programs to manage expenses while pursuing quality education in this specialized field. Balancing affordability with comprehensive training can set a solid foundation for a rewarding healthcare career linked to immunology.

Best Scientists Citing Ivelin S. Georgiev

Trending Scientists

Recently Published Articles